Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3115-3119

  Poretsky, Leonid ^a,b,c   Seto Young, Donna ^a   Shrestha, Anil ^a   Dhillon, Sandeep ^b   Mirjany, Mana ^b   Liu, Hung Ching ^b   Yih, Melissa C ^b   Rosenwaks, Zev ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; SOMATOMEDIN BINDING PROTEIN 1; WORTMANNIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE MUTATION; GLUCOSE TRANSPORT; GRANULOSA CELL; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERANDROGENISM; INSULIN RESISTANCE; ONCOGENE; OVARY; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BREAST NEOPLASMS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FERTILIZATION IN VITRO; GENES, BRCA1; GRANULOSA CELLS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MUTATION; OVARY; PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 0034917780     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.3115     Document Type: Article

References (29)

1. The syndromes of insulin resistance and acanthosis nigricans: Insulin-receptor disorders in man
2. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance
3. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states
4. Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor
5. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
6. The insulin-related regulatory system in health and disease
7. The insulin signaling system and the IRS proteins
8. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes
9. Characterization of insulin-like growth factor I binding to human granulosa cells obtained during in vitro fertilization
10. Distribution and characterization of the insulin and IGF-I receptors in the human ovary
11. Hormonally active long-term culture of human ovarian cells: Initial characterization
12. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle
13. Wortmannin: A potent phosphatidylinositol 3-kinase inhibitor
14. Role of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyribonucleic acid synthesis by insulin-like growth factor-I
15. A link between insulin resistance and hyperinsulinemia: Inhibitor of phosphotidylinositiol 3-kinase augments glucose-induced insulin secretion from islet of lean, but not obese, rats
16. Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats
17. Dual defect hypothesis of the polycystic ovary syndrome
18. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
19. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
20. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
21. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome
22. Decreases in ovarian cytochrome P450c17á activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
23. Insulin and the polycystic ovary syndrome
24. Insulin receptor mediates inhibitory effect of insulin, but not of IGF-I, on insulin-like growth factor binding protein 1 (IGFBP-I) production in human granulosa cells
25. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor
26. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system
27. Second messengers of insulin action
28. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression block differentiation of L6E9 muscle cells
29. Molecular and cellular aspects of the insulin-like growth factor I receptor